Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/b5/3f/05/b53f0540-2e41-5eef-5b4d-85147edd72bb/mza_6743734897382085792.jpg/600x600bb.jpg
JNIS Podcast
BMJ Group
98 episodes
1 week ago
The Journal of NeuroInterventional Surgery (JNIS) Podcast is your source for a comprehensive look at the latest scientific research and literature in the field of neurointerventional surgery. Hosted by Editor-in-Chief, Dr. Felipe C. Albuquerque, each episode features in-depth interviews with authors and leading experts. Stay informed on the latest neurointerventional techniques for the treatment of a range of neurological and vascular problems including stroke, aneurysms, brain tumours, and spinal disorders. Subscribe here or listen on your favourite podcast platform. JNIS - jnis.bmj.com - is published by BMJ on behalf of the Society of NeuroInterventional Surgery. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Show more...
Medicine
Health & Fitness
RSS
All content for JNIS Podcast is the property of BMJ Group and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Journal of NeuroInterventional Surgery (JNIS) Podcast is your source for a comprehensive look at the latest scientific research and literature in the field of neurointerventional surgery. Hosted by Editor-in-Chief, Dr. Felipe C. Albuquerque, each episode features in-depth interviews with authors and leading experts. Stay informed on the latest neurointerventional techniques for the treatment of a range of neurological and vascular problems including stroke, aneurysms, brain tumours, and spinal disorders. Subscribe here or listen on your favourite podcast platform. JNIS - jnis.bmj.com - is published by BMJ on behalf of the Society of NeuroInterventional Surgery. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Show more...
Medicine
Health & Fitness
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/b5/3f/05/b53f0540-2e41-5eef-5b4d-85147edd72bb/mza_6743734897382085792.jpg/600x600bb.jpg
Point/Counterpoint: Stenting for idiopathic intracranial hypertension
JNIS Podcast
32 minutes 22 seconds
2 years ago
Point/Counterpoint: Stenting for idiopathic intracranial hypertension
In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Michael Levitt (1) and Dr. Colin Derdeyn (2), authors of a pair of editorials discussing the practice of dural venous sinus stenting for patients with idiopathic intracranial hypertension.   Point: Dural venous sinus stenting should be considered a first-line treatment option for select patients with idiopathic intracranial hypertension https://jnis.bmj.com/content/early/2023/06/20/jnis-2023-020597  Counterpoint: stenting for idiopathic intracranial hypertension should be trialedhttps://jnis.bmj.com/content/early/2023/06/20/jnis-2023-020404    These articles are free-to-access for a month following the publication of this podcast.    Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767  Thank you for listening! This episode was edited by Brian O'Toole.    (1) Neurological Surgery, University of Washington School of Medicine, Seattle, Washington, USA(2) Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
JNIS Podcast
The Journal of NeuroInterventional Surgery (JNIS) Podcast is your source for a comprehensive look at the latest scientific research and literature in the field of neurointerventional surgery. Hosted by Editor-in-Chief, Dr. Felipe C. Albuquerque, each episode features in-depth interviews with authors and leading experts. Stay informed on the latest neurointerventional techniques for the treatment of a range of neurological and vascular problems including stroke, aneurysms, brain tumours, and spinal disorders. Subscribe here or listen on your favourite podcast platform. JNIS - jnis.bmj.com - is published by BMJ on behalf of the Society of NeuroInterventional Surgery. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.